Frazier Life Sciences Management’s Alkermes ALKS Stock Holding History
Bought
Maintained
Sold
Other funds holding ALKS
BBA
Frazier Life Sciences Management's ALKS Position: Q3 2026 in Review
Frazier Life Sciences Management sold out of Alkermes (ALKS) in Q3 2026, closing a stake of 700,647 shares — an estimated $36.7M sold.
Frazier Life Sciences Management first reported a position in ALKS in Q3 2024 and held it in 8 quarters. The position peaked at $36.7M in Q2 2026. 410 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.
- Frazier Life Sciences Management reported no remaining Alkermes position as of Q3 2026 after selling out during the quarter.
- Frazier Life Sciences Management sold 700,647 Alkermes shares in Q3 2026, an estimated $36.7M.
- Frazier Life Sciences Management first reported a position in Alkermes in Q3 2024 and held it in 8 quarters.
- Frazier Life Sciences Management's Alkermes position peaked at $36.7M in Q2 2026.
- 410 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.
Based on Frazier Life Sciences Management's 13F filing for Q3 2026, filed 16 Nov 2026.